Whole Shine Medical Technology Co., Ltd.

Total Valuation

Whole Shine Medical Technology Co., Ltd. carries a market capitalization of 1.82B, placing it among publicly traded companies globally. Its enterprise value stands at 2.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Whole Shine Medical Technology Co., Ltd. currently has 840.00M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 4.83, and the price-to-book ratio stands at 9.08.

Enterprise Valuation

On an enterprise value basis, Whole Shine Medical Technology Co., Ltd. trades at an EV/EBITDA multiple of 12.66 and an EV/FCF ratio of 53.57. The EV/Sales ratio of 5.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.66 provides insight into valuation relative to core operating earnings.

Financial Position

Whole Shine Medical Technology Co., Ltd. maintains a current ratio of 0.29, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 146.05, indicating elevated leverage, while an interest coverage ratio of -0.89 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Whole Shine Medical Technology Co., Ltd.'s stock has declined approximately -23.32155% over the past 52 weeks. The 50-day moving average sits at 2.52, while the 200-day moving average is 2.93.

Income Statement

Over the trailing twelve months, Whole Shine Medical Technology Co., Ltd. generated 481.51M in revenue and converted that into -112.89M in net income, yielding earnings per share of -0.15. EBITDA reached -26.15M, while operating income came in at -26.15M.

Balance Sheet

Whole Shine Medical Technology Co., Ltd. holds 136.04M in cash and equivalents against 448.68M in total debt, resulting in a net debt position of 54.86M. Total book value stands at 256.14M, with working capital of -642.61M providing operational flexibility.

Cash Flow

After subtracting -19.59M in capital expenditures, free cash flow totaled -19.59M - equivalent to -0.02 per share.

Margins

Whole Shine Medical Technology Co., Ltd. operates with a gross margin of 43.17, reflecting its pricing power and cost economics. The operating margin of -5.43 and net profit margin of -23.44 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -7.96 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Whole Shine Medical Technology Co., Ltd.'s most recent stock split took place on May 19, 2016 with a 1:2 split ratio.

Scores

Whole Shine Medical Technology Co., Ltd. posts an Altman Z-Score of 0.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.